|
|
Office Locations:
|
777 Third Avenue, 25th Floor
New York, NY 10017
Phone: 212-698-4580
| | |
|
|
|
|
|
Business Services
Financial Services
Information Technology
Life Sciences & Healthcare
Manufacturing & Industrial
Software & Internet
|
|
|
|
Innovatus Capital Partners is an independent adviser and portfolio management firm with ~$1.9B in assets under management. Innovatus' investment objective is to identify and capitalize on market distress, disruption, and growth. The team targets lower middle market and middle market companies with revenues of $25 - $250 million with typical deal sizes from $10 - $50 million. Innovatus Capital Partners' Life Sciences strategy provides growth capital in the form of senior secured debt and equity to support life sciences and select technology companies, including medical devices, diagnostics, life science tools, biopharmaceuticals, specialty pharmaceuticals, healthcare IT and software. The Firm seeks to invest $20 to $50 million in public and private commercial-stage companies and offer flexible financing solutions to fund rapid commercial growth and development programs.
|
|
|
|
|
|
|
Investment Firm Key
VC = Venture Capital
PE = Private Equity
A = Angel
I = Incubator
MB = Merchant Bank
VD = Venture Debt
FI = Family Investment Office
FOF = Fund of Funds
ED = Economic Development Office
TT = Technology Transfer Office
CVC = Corporate Venture Capital
SEC = Secondary Purchaser
HF = Hedge Fund/Mutual Fund
|
|
| COMPANY STAGE | REVENUE |
| Venture Capital | |
Seed Stage
(includes "pre-seed," or
concept stage) | No Revenue |
| Early Stage | Minimal
Revenue |
Growth Stage
(also called Mid-stage) | $2M-$7M |
Expansion Stage
(also called Late-stage) | $7M and greater |
| Private Equity | |
| Lower Middle Market | $10M-$249M |
| Middle Market | $250M-$499M |
| Upper Middle Market | $500M-$1B |
| Large Cap | >$1B |
|
|
|
|
|
